← Evidence map

ArticleNPJ Parkinson's disease2024

G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage.

Nicholas Pena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38429321